Q3 2025
Released Nov 5, 2025, after the close
10-Q filed Nov 6, 2025, 37 days after period end · 0001653477-25-000127
Q3 2025 · 10-Q
Revenue$333.10M$333.10M −0.2% vs Q3 2024+0.5% vs Q2 2025
Net Income$43.50M$43.50M N/M vs Q3 2024N/M vs Q2 2025
EPS Diluted$1.18$1.18 N/M vs Q3 2024N/M vs Q2 2025
Gross Profit$133,900,000+1.7%
Operating Cash Flowderived$129,700,000+178.9%
Free Cash Flowderived$117,800,000+313.3%
Margins · derived
Gross margin40.2%+0.8 pt vs Q3 2024
Net margin13.1%+45.2 pt vs Q3 2024
What the release said
The release
Same quarter
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $333.10M | $333.80M | $446.00M | $482.00M |
| Net Income | $43.50M | -$107.20M | $25.20M | $75.40M |
| EPS Diluted | $1.18 | -$2.94 | $0.69 | $1.98 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR